
Tirz GLP-2
Tirzepatide is a novel investigational peptide that acts as a dual agonist of GIP and GLP-1 receptors, enhancing insulin secretion and improving glycemic contro…
Half-life
5 days
Delivery
Subcutaneous injection
Suggested dosage
Not specified
Usage
Mechanism of action
Benefits (4)
- Improved insulin sensitivity
- Appetite suppression
- Significant weight loss
- Better glycemic control
Side effects (4)
- Nausea
- Vomiting
- Constipation
- Fatigue (in early dosing phase)

